Presentation TCT 2025 TCT 1017: Percutaneous PFO Closure Versus Medical Therapy for Prevention of Recurrent Stroke in Patients With Cryptogenic Stroke: A Comparative Clinical Outcomes Analysis Presenter: Mehmet Cilingiroglu October 28, 2025
Presentation TCT 2024 TCT 311: Identifying Success Factors for Patent Foramen Ovale Closure in Cryptogenic Stroke Presenter: Yoonsun Won October 29, 2024
Presentation TCT 2023 Close It: Age Is Unimportant if the Cryptogenic Stroke w/u Was Negative Presenter: David Thaler October 26, 2023
Presentation TCT 2023 TCT 445: Almost Half of PFO Related Cryptogenic Strokes are Non-Cortical Presenter: Mohammed Ebrahim October 24, 2023
Presentation TCT 2022 TCT 377: Automated Robotic TCD for RLS detection in the evaluation of patients with Cryptogenic Stroke Presenter: Ruchir Shah September 19, 2022
Presentation TCT 2018 A Patient With Atrial Fibrillation, Cryptogenic Stroke, and PFO: Watchman Despite OAC? Presenter: Zahid Amin, Robert J. Sommer, Peter C. Block, John P. Breinholt, Craig E Fleishman, Jan Kovac, Harsimran Sachdeva Singh, Christian Spies September 24, 2018
Presentation TCT 2018 A Patient With a PFO and Cryptogenic Stroke Outside the Recommended Age Range: Is PFO Closure Appropriate? Presenter: Zahid Amin, Robert J. Sommer, Peter C. Block, John P. Breinholt, Craig E Fleishman, Jan Kovac, Harsimran Sachdeva Singh, Christian Spies September 24, 2018
Presentation TCT 2018 Updated RCT Data for PFO Closure in All-Comers and Subgroups With Cryptogenic Stroke: How Should the Guidelines Be Updated? Presenter: Teiji Akagi, John D. Carroll, Konstantinos Dean Boudoulas September 22, 2018
Presentation TCT 2018 Case #1: Should This PFO Be Closed in a Patient With A Cryptogenic Stroke? Presenter: Teiji Akagi, John D. Carroll, Lee N. Benson, Stefan C. Bertog, Clifford J. Kavinsky, David W.M. Muller, Francesco Pelliccia, A.J. Conrad C. Smith September 22, 2018
Presentation TCT 2017 What is Appropriate Evaluation of Cryptogenic Stroke, and When is a Hypercoagulability Work-up Needed? Presenter: Lee N. Benson, Megan Coylewright, David E. Thaler November 01, 2017
Presentation TCT 2017 PFO Closure in Cryptogenic Stroke Presenter: David Hildick-Smith, Lars Sondergaard October 29, 2017
Presentation TCT 2016 Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do? Presenter: Eustaquio Maria Onorato, Richard Smalling, Robert J. Sommer November 01, 2016
Presentation TCT 2016 The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed? Presenter: Eustaquio Maria Onorato, Richard Smalling, David E. Thaler November 01, 2016
Presentation TCT 2016 Case #2 - Introduction: Cryptogenic Stroke: Is the Foramen Ovale Involved? Presenter: John D. Carroll, David E. Thaler, Ted Feldman November 01, 2016
Presentation TCT 2016 RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke Presenter: Howard C. Herrmann, Robert J. de Winter, David E. Thaler November 01, 2016
Presentation TCT 2015 RESPECT: A Prospective Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke Long-term Results Presenter: John D. Carroll, Ioanna Kosmidou October 15, 2015
Presentation TCT 2015 RESPECT: A Prospective Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke – Long-term Results Presenter: John D. Carroll October 15, 2015
Presentation TCT 2014 ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community? Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, David E. Thaler September 13, 2014
Presentation TCT 2012 RESPECT: A Prospective, Randomized Trial of PFO Closure vs. Medical Therapy in Patients with Cryptogenic Stroke Presenter: John Carroll October 25, 2012
Presentation TCT 2012 Cryptogenic Stroke vs PFO Stroke? Neurology Perspectives Presenter: David Thaler October 22, 2012